ADVM is currently covered by 5 analysts with an average potential upside of $3.89 (59.86%) backed by displayed 56 price targets and 63 ratings.
Analysts average stock forecasts to be materialized ratio is 66.86% with an average time for these price targets to be met of 95.1 days.
Highest price target for ADVM is 3, Lowest price target is 1, average price target is 2. For detailed individual stock analysts price targets on ADVM go to the chart section.
Most recent stock forecast was given by DANIIL GATAULIN from CHARDAN CAPITAL on 11-Nov-2022. First documented stock forecast 19-Feb-2015.
Currently, out of the existing stock ratings of ADVM - 5 which are a Hold (83.33%), 1 which are a Buy (16.67%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
2
$0.52 (35.14%)
2.5
6 months 28 days ago
0/2 (0%)
$1.13 (114.91%)
Buy
4
$2.52 (170.27%)
9
11 months 1 days ago
4/6 (66.67%)
$1.45 (57.70%)
24
Hold
3
$1.52 (102.70%)
17
1 years 10 months 16 days ago
1/2 (50%)
$2.74 (33.46%)
7
Hold
2
$0.52 (35.14%)
5
1 years 10 months 16 days ago
3/5 (60%)
$3.07 (29.73%)
47
Hold
21
1 years 10 months 16 days ago
2/2 (100%)
$7.53 (88.83%)
197
What is ADVM(Adverum Biotechnologies, Inc) average time for price targets to be met?
Which analyst has the current highest performing score on ADVM(Adverum Biotechnologies, Inc) with a proven track record?